Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 23

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 23
---
 it was acquired by Shire Pharmaceuticals. From April 2009 to January 2014, she held positions of increasing responsibility at Daiichi Sankyo Pharma Development, most recently serving as Director of Human Resources. Earlier in her career, from November 2002 to April 2009, Ms. Neufeld held various human resources positions at Johnson & Johnson, including Manager of Human Resources in the consumer division and its oncology company called Ortho Biotech. Ms. Neufeld earned a B.A. in psychology from the American University and an M.S. in career counseling and organization development from Johns Hopkins University.

<div align='center'>16</div>

TABLE OF CONTENTS

### CORPORATE GOVERNANCE

#### Corporate Governance Guidelines
Our Board of Directors has adopted Corporate Governance Guidelines. A copy of these Corporate Governance Guidelines can be found in the “Governance — Documents & Charters” section of the “For Investors” page of our website located at www.ir.immuneering.com , or by writing to our Secretary at our offices at 245 Main Street, Second Floor, Cambridge, MA 02142. Among the topics addressed in our Corporate Governance Guidelines are:

| — Board size, independence and qualifications   |     | — Stock ownership                                     |
| — Executive sessions of independent directors   |     | — Board access to senior management                   |
| — Board leadership structure                    |     | — Board access to independent advisors                |
| — Selection of new directors                    |     | — Board self-evaluations                              |
| — Director orientation and continuing education |     | — Board meetings                                      |
| — Limits on board service                       |     | — Meeting attendance by directors and non-directors   |
| — Change of principal occupation                |     | — Meeting materials                                   |
| — Term limits                                   |     | — Board committees, responsibilities and independence |
| — Director responsibilities                     |     | — Succession planning                                 |
| — Director compensation                         |     | — Risk management                                     |

#### Board Leadership Structure
Our Corporate Governance Guidelines provide our Board of Directors with flexibility to combine or separate the positions of Chair of the Board and Chief Executive Officer in accordance with its determination that utilizing one or the other structure would be in the best interests of our Company and our stockholders. If the Chair of the Board of Directors is a member of management or does not otherwise qualify as independent, our Corporate Governance Guidelines allow for the appointment by the independent directors of a lead independent director. The lead independent director’s responsibilities include, but are not